Form 8-K - Current report:
SEC Accession No. 0001437749-24-030185
Filing Date
2024-09-27
Accepted
2024-09-27 16:18:06
Documents
15
Period of Report
2024-09-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atxi20240927_8k.htm   iXBRL 8-K 26863
2 EXHIBIT 10.1 ex_727900.htm EX-10.1 29668
  Complete submission text file 0001437749-24-030185.txt   197604

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20240923.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20240923_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20240923_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20240923_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT atxi20240927_8k_htm.xml XML 2847
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 241335111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)